The Design–Generate–Test–Learn (DGTL) cycle represents an efficient approach to biological engineering, from single-gene to whole-genome scale. Significant improvement can be achieved in a short ...
Therapeutic protein design is evolving—and it is doing so in more than one sense of that word. Protein design is being guided by artificial intelligence (AI), which drug developers are using to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results